Advertisement
Research Article

Effective Post-Exposure Treatment of Ebola Infection

  • Heinz Feldmann equal contributor mail,

    equal contributor Contributed equally to this work with: Heinz Feldmann, Steven M Jones

    To whom correspondence should be addressed. E-mail: Heinz_Feldmann@phac-aspc.gc.ca (HF); Steven_Jones@phac-aspc.gc.ca (SMJ)

    Affiliations: Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

    X
  • Steven M Jones equal contributor mail,

    equal contributor Contributed equally to this work with: Heinz Feldmann, Steven M Jones

    To whom correspondence should be addressed. E-mail: Heinz_Feldmann@phac-aspc.gc.ca (HF); Steven_Jones@phac-aspc.gc.ca (SMJ)

    Affiliations: Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada, Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada

    X
  • Kathleen M Daddario-DiCaprio,

    Affiliations: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

    X
  • Joan B Geisbert,

    Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Ute Ströher,

    Affiliations: Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada, Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada

    X
  • Allen Grolla,

    Affiliation: Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

    X
  • Mike Bray,

    Affiliation: Biodefense Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Elizabeth A Fritz,

    Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Lisa Fernando,

    Affiliation: Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

    X
  • Friederike Feldmann,

    Affiliation: Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada

    X
  • Lisa E Hensley,

    Affiliation: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America

    X
  • Thomas W Geisbert

    Affiliations: Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, United States of America, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

    X
  • Published: January 19, 2007
  • DOI: 10.1371/journal.ppat.0030002

Reader Comments (0)

Post a new comment on this article